Perflexane

Summary

Perflexane (CHEMBL1200607) is an approved small-molecule radioopaque medium.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• Chemistry: 338.04 Da · C6F14

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL1200607
Name	Perflexane
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	9639
ChEBI	CHEBI:39427
Molecular formula	C6F14
Molecular weight	338.04
InChIKey	ZJIJAJXFLBMLCK-UHFFFAOYSA-N

SMILES: C(C(C(C(F)(F)F)(F)F)(F)F)(C(C(F)(F)F)(F)F)(F)F

IUPAC name: 1,1,1,2,2,3,3,4,4,5,5,6,6,6-tetradecafluorohexane

ChEBI definition: A fluoroalkane that is hexane in which all of the hydrogens have been replaced by fluorines.

Pharmacological roles (ChEBI): radioopaque medium.

Also known as: AF-0150, AF0150, Perflexane, Perflexane component of imagent, Perflexano, Perfluorohexane, PERFLEXANE, SID144205881

Patent coverage: 6,729 distinct patent families (21,417 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).